Middle East respiratory syndrome coronavirus (MERS-CoV)

Middle East respiratory syndrome coronavirus (MERS-CoV)
====================================================


MERS Monthly Summary, November 2019
At the end of November 2019, a total of 2494 laboratory-confirmed cases of Middle East respiratory syndrome (MERS), including 858 associated deaths (case–fatality rate: 34.4%) were reported globally; the majority of these cases were reported from Saudi Arabia (2102 cases, including 780 related deaths with a case–fatality rate of 37.1%).

MERS-CoV situation update from the Eastern Mediterranean Region

MERS Global Summary and Assessment of Risk
2 August 2019 - Overall, the epidemiology, transmission patterns, clinical presentation of MERS patients and viral characteristics reported since the last update are consistent with past patterns described in previous WHO risk assessments: MERS-CoV is a zoonotic virus that has repeatedly entered the human population via direct or indirect contact with infected dromedary camels in the Arabian Peninsula. Limited, non-sustained human-to-human transmission mainly in health care settings continues to occur, primarily in Saudi Arabia. The risk of exported cases to areas outside of the Middle East due to travel remains significant.


Worldwide reduction in MERS cases and deaths since 2016
8 July 2019 - WHO and colleagues from the University of Oxford, Imperial College London and Institut Pasteur have estimated that, since 2016, 1,465 cases of Middle East Respiratory syndrome coronavirus (MERS-CoV) and between 300 and 500 deaths may have been averted due to accelerated global efforts to detect infections early and reduce transmission.

Source :
https://www.who.int/emergencies/mers-cov/e
Pls go to site if you want to read WHO summary or if you want to read the full research Letter published in the journal Emerging Infectious Diseases